New task order under IDIQ contract HHSF223201610004I, entitled "pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products
Ended Awarded Last action
- Contract number
- 75F40119F19004
- Awardee
-
Biopharma Services USA UEI DRLXCANKKNN6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,470,791
Award facts
- Contract value 100% obligated
- $2,470,791.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- B528 Special Studies/Analysis- Regulatory
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MO 65201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $209,491 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $412,169 | |
| Original award | $1,849,131 |
About this award
This is a new task order awarded under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSF223201610004I) with the Department of Health and Human Services Food and Drug Administration (FDA). The task order, valued at $2,470,791.00, is for a Pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products. The study falls under the FDA's In Vivo Study of Generic Drug Products in Human Subjects program. The contract is a Firm Fixed Price Delivery Order, awarded to Biopharma Services USA Inc., a foreign-owned, self-certified small disadvantaged business. The place of performance is in Columbia, Missouri. The contract does not have a set-aside designation and is set to be completed by May 31, 2023.
Quick answers
Who was awarded contract 75F40119F19004?
75F40119F19004 was awarded to Biopharma Services USA by Food and Drug Administration (Department of Health and Human Services) on September 16, 2019.
How much is contract 75F40119F19004 worth?
The government has obligated $2,470,791 on 75F40119F19004.
Is contract 75F40119F19004 an order under another contract?
Yes. 75F40119F19004 is a delivery order under HHSF223201610004I, an indefinite delivery contract.
Was contract 75F40119F19004 competed?
The extent of competition for 75F40119F19004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award